)

MedinCell (MEDCL) investor relations material
MedinCell Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key clinical findings
No cases of post-injection delirium/sedation syndrome (PDSS) were observed through week 56 in the pivotal Phase 3 SOLARIS trial for olanzapine LAI, supporting a favorable safety profile.
The long-term systemic safety profile of olanzapine LAI was consistent with other olanzapine formulations, with most common adverse events being weight increase, injection site reactions, and somnolence.
Serious adverse events occurred in 6% of participants, and 8% discontinued due to treatment-emergent adverse events.
Long-term effectiveness data showed maintained symptom improvement and stable clinical effectiveness, with improvements in PANSS, CGI-S, and PSP scores.
Weight and metabolic changes were comparable to existing oral and intramuscular olanzapine formulations, with mean weight gain stabilizing after 32 weeks.
Regulatory and commercial update
Teva plans to submit a New Drug Application (NDA) for olanzapine LAI in the US in Q4 2025, aiming to address a critical treatment gap in schizophrenia.
Olanzapine LAI is the second product in the Teva partnership using Medincell's co-polymer technology, following the FDA-approved UZEDY®.
Medincell is entitled to royalties on net sales and milestone payments upon commercialization.
Technology and innovation
Olanzapine LAI uses Steady Teq™, a proprietary copolymer technology enabling controlled, steady drug release throughout the dosing interval.
The formulation is designed to eliminate the risk of PDSS, potentially improving safety and accessibility for patients.
Next MedinCell earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage